Related Experiment Video
Updated: Jul 6, 2026
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty
Insights
Low high-density lipoprotein (HDL) cholesterol is strongly linked to restenosis after percutaneous transluminal coronary angioplasty (PTCA). This finding suggests that managing lipid levels may help prevent restenosis in patients undergoing PTCA.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Investigating risk factors for restenosis after percutaneous transluminal coronary angioplasty (PTCA).
- Examining the role of serum lipid profiles and endogenous fibrinolytic factors in post-PTCA outcomes.
Purpose of the Study:
- To determine the relationship between post-PTCA restenosis and serum lipid fractions.
- To assess the association of circulating levels of endogenous tissue plasminogen activator (t-PA) and its inhibitor (PAI-1) with restenosis.
Main Methods:
- Studied 68 patients with coronary artery disease who underwent successful PTCA.
- Monitored patients for a mean follow-up of 9 months to identify restenosis.
- Analyzed serum lipid fractions and PAI-1 levels in relation to restenosis development.
Main Results:
- 41% of patients developed restenosis within the follow-up period.
- Low high-density lipoprotein (HDL) cholesterol was a significant independent predictor of restenosis risk (p<0.001) and time to restenosis (p=0.03).
- Patients with HDL cholesterol ≤40 mg% had a significantly higher restenosis rate (64%) compared to those with HDL >40 mg% (17%). A low PAI-1 level was also related to restenosis (p=0.04).
Conclusions:
- A low HDL cholesterol level is strongly associated with an increased risk of restenosis after PTCA.
- Lipid fractions, particularly HDL cholesterol, may play a crucial role in the pathogenesis and prevention of coronary restenosis.
- Further research into lipid management strategies for preventing post-PTCA restenosis is warranted.
Background:
To determine the relation of post-percutaneous transluminal coronary angioplasty (PTCA) restenosis to serum lipid fractions and to circulating levels of endogenous tissue plasminogen activator (t-PA) and its rapid inhibitor (PAI-1), 68 patients with coronary artery disease who underwent a successful PTCA were studied.
Methods And Results:
During a mean follow-up of 9 months (range, 7-11 months), 28 (41%) patients developed restenosis. A low high density lipoprotein (HDL) cholesterol level was independently and strongly related to both the risk of restenosis (p less than 0.001) and to the time of restenosis (p = 0.03). The mean HDL cholesterol level was 33 +/- 12 mg% in the restenosis group compared with 45 +/- 12 mg% in the nonrestenosis group (p less than 0.001). Restenosis developed in 22 of 34 (64%) patients with an HDL cholesterol less than or equal to 40 mg% compared with six of 34 (17%) patients with an HDL cholesterol greater than 40 mg% (p less than 0.002). The only other variable that was significantly related to restenosis was a low PAI-1 level (p = 0.04).
Conclusions:
The strong relation between a low HDL cholesterol level and the risk of restenosis suggests that lipid fractions could be important in the pathogenesis and prevention of restenosis.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management